Agilent Technologies Inc. (NYSE: A) today announced it is collaborating with Florida International University’s department of chemistry and biochemistry and its International Forensics Research Institute to further advance the identification and characterization of so-called designer drugs. This work is currently focused on developing and validating new methods for rapid forensic screening and analysis based on […]
Both the Radiometer and HemoCue companies are leading in their respective fields of point-of-care, or near-patient testing. The transaction is expected to be completed in March 2013, subject to customary closing conditions. Assuming the acquisition’s completion, Radiometer and HemoCue will continue operations as separate companies and brands. This acquisition will enable both HemoCue and Radiometer […]
Biocartis will use this IWT-subsidy (from the Flemish government) to develop new diagnostic cancer tests that will facilitate more targeted treatment and improve survival rates for patients. Biocartis is a molecular diagnostics company that develops clinically relevant tests and innovative, easy-to-use platforms to be employed, amongst other indications, in the fight against cancer. With this […]
IRVINE, Calif., — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that Mark McDonough, currently the Company’s Chief Commercial Officer, will become Chief Executive Officer following the retirement of CEO R. Judd Jessup, who has announced his retirement, effective March 15, 2013. McDonough, a resident […]
WALTHAM, Mass.,— N-of-One, Inc., a leading provider of molecular interpretation and therapeutic strategies for personalized cancer care, today announced a partnership with Fox Chase Cancer Center in Philadelphia, to provide molecular interpretation and treatment strategy analysis for genome sequencing and testing provided to advanced stage cancer patients through the Cancer Genome Institute at Fox Chase. […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced it has completed its previously announced acquisition of Verinata Health, Inc., a leading provider of non-invasive tests for the early identification of fetal chromosomal abnormalities. As of the close, Verinata Health became a wholly owned subsidiary of Illumina. “We look forward to working with the talented […]
BEDFORD, Mass., — Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that it has commenced a registered exchange offer (the Exchange Offer) to exchange up to $1 billion aggregate […]
Hercules, California, and Lugano, Switzerland — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, and Inpeco, a leading company in the field of laboratory automation, today announced that they have entered into a development agreement to build interfaces between Bio-Rad’s clinical diagnostics platforms […]
Marco Island, Florida, and Hilden, Germany,— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today provided new insights into its next-generation sequencing (NGS) initiative, unveiling an innovative sample-to-result NGS workflow designed to enable the routine use of this breakthrough technology beyond life sciences research in areas such as clinical research and diagnostics. QIAGEN’s NGS workflow […]
SAN CARLOS, Calif., – Natera, a leading innovator in reproductive and prenatal genetic testing, today announced that the company’s non-invasive prenatal screening test, Panorama™, will launch on March 1 for the detection of trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and select sex chromosome abnormalities, such as monosomy X (Turner’s […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
